Literature DB >> 26977546

Bone Marrow Edema: Chronic Bone Marrow Lesions of the Knee and the Association with Osteoarthritis.

Jason A Collins, Bryan G Beutel, Eric Strauss, Thomas Youm, Laith Jazrawi.   

Abstract

Bone marrow edema of the knee occurs secondary to a myriad of causes. The hallmark of a bone marrow lesion (BML) is an area of decreased signal intensity on T1 weighted MRI with a corresponding area of increased signal intensity on a T2 weighted MRI. Recently, chronic bone marrow lesions have been correlated with knee pain and progression of osteoarthritis. These lesions have also been associated with other degenerative conditions such as meniscal tears, cartilage deterioration, subchondral cyst formation, mechanical malalignment, and ultimately progression to arthroplasty. Medical treatments, such as prostacyclin and bisphosphonate therapy, have shown promise. Alignment procedures, as well as core decompression and subchondroplasty, have been used as surgical treatments for chronic BMLs.

Entities:  

Mesh:

Year:  2016        PMID: 26977546

Source DB:  PubMed          Journal:  Bull Hosp Jt Dis (2013)        ISSN: 2328-4633


  4 in total

1.  Common Mistakes and Pitfalls in Magnetic Resonance Imaging of the Knee.

Authors:  Filip Vanhoenacker; Nicolas De Vos; Pieter Van Dyck
Journal:  J Belg Soc Radiol       Date:  2016-11-19       Impact factor: 1.894

2.  Time- and Kellgren⁻Lawrence Grade-Dependent Changes in Intra-Articularly Transplanted Stromal Vascular Fraction in Osteoarthritic Patients.

Authors:  Tung Dang Xuan Tran; Chi-Ming Wu; Navneet Kumar Dubey; Yue-Hua Deng; Chun-Wei Su; Tu Thanh Pham; Phuong Bich Thi Le; Piero Sestili; Win-Ping Deng
Journal:  Cells       Date:  2019-04-03       Impact factor: 6.600

Review 3.  Bisphosphonates therapy for osteoarthritis: a meta-analysis of randomized controlled trials.

Authors:  R L Xing; L R Zhao; P M Wang
Journal:  Springerplus       Date:  2016-10-03

4.  Complement Expression and Activation in Osteoarthritis Joint Compartments.

Authors:  Elisa Assirelli; Lia Pulsatelli; Paolo Dolzani; Erminia Mariani; Gina Lisignoli; Olga Addimanda; Riccardo Meliconi
Journal:  Front Immunol       Date:  2020-10-29       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.